Psychoneuroendocrinology
Volume 33, Issue 8 , Pages 1051-1060 , September 2008

Estradiol–sertraline synergy in ovariectomized rats

  • Stacy L. Sell

      Affiliations

    • Center for Addiction Research, Department of Pharmacology & Toxicology, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555-1031, United States
    • Corresponding Author InformationCorresponding author. Present address: Department of Anesthesiology, University of Texas Medical Branch, Galveston, TX 77555-0830, United States. Tel.: +1 409 747 0717; fax: +1 409 772 6348.
    • ,
  • Rebecca M. Craft

      Affiliations

    • Department of Psychology, Washington State University, Pullman, WA 99164-4820, United States
    • ,
  • Patricia K. Seitz

      Affiliations

    • Center for Addiction Research, Department of Pharmacology & Toxicology, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555-1031, United States
    • ,
  • Sonja J. Stutz

      Affiliations

    • Center for Addiction Research, Department of Pharmacology & Toxicology, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555-1031, United States
    • ,
  • Kathryn A. Cunningham

      Affiliations

    • Center for Addiction Research, Department of Pharmacology & Toxicology, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555-1031, United States
    • These authors contributed equally to this work.
    • ,
  • Mary L. Thomas

      Affiliations

    • Center for Addiction Research, Department of Pharmacology & Toxicology, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555-1031, United States
    • These authors contributed equally to this work.
    • Address: Department of Pharmacology, RUSM – Dominica, 499 Thornall St. 10th Floor, Edison, NJ 08837-2235, United States.

Received 30 January 2008 ,Revised 11 April 2008 ,Accepted 9 May 2008.

References 

  1. Andrade TGCS, Nakamuta JS, Avanzi V, Graeff FG. Anxiolytic effects of estradiol in the median raphe nucleus mediated by 5-HT1A receptors. Behav. Brain Res. 2005;163:18–25
  2. Anthony JP, Sexton TJ, Neumaier JF. Antidepressant-induced regulation of 5-HT1B mRNA in rat dorsal raphe nucleus reverses rapidly after drug discontinuation. J. Neurosci. Res. 2000;61:82–87
  3. Bethea CL, Mirkes SJ, Su A, Michelson D. Effects of oral estrogen, raloxifene and arzoxifene on gene expression in serotonin neurons of macaques. Psychoneuroendocrinology. 2002;27:431–445
  4. Benvenga MJ, Leander JD. Antidepressant-like effect of LY228729 as measured in the rodent forced swim paradigm. Eur. J. Pharmacol. 1993;239:249–252
  5. Borsini F, Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity?. Psychopharmacology. 1988;94:147–160
  6. Borsini F. Role of the serotonergic system in the forced swimming test. Neurosci. Biobehav. Rev. 1995;19:377–395
  7. Bridges RS. A quantitative analysis of the roles of dosage, sequence, and duration of estradiol and progesterone exposure in the regulation of maternal behavior in the rat. Endocrinology. 1984;114:930–940
  8. Craft RM. Modulation of pain by estrogens. Pain. 2007;132:S3–S12
  9. Cryan JF, Valentino RJ, Lucki I. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci. Biobehav. Rev. 2005;29:547–569
  10. Cyr M, Landry M, Di Paolo T. Modulation by estrogen-receptor directed drugs of 5-hydroxytryptamine-2A receptors in rat brain. Neuropsychopharmacology. 2000;23:69–78
  11. Detke MJ, Rickels M, Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl.). 1995;121(1):66–72
  12. Dvorak Z, Pascussi JM, Modriansky M. Approaches to messenger RNA detection—comparison of methods. Biomed. Papers. 2003;147(2):131–135
  13. Estrada-Camarena E, Fernandez-Guasti A, Lopez-Rubalcava C. Antidepressant-like effect of different estrogenic compounds in the forced swimming test. Neuropsychopharmacology. 2003;28:830–838
  14. Estrada-Camarena E, Fernandez-Guasti A, Lopez-Rubalcava C. Interaction between estrogens and antidepressants in the forced swimming test in rats. Psychopharmacology. 2004;173:139–145
  15. Estrada-Camarena E, Lopez-Rubalcava C, Fernandez-Guasti A. Facilitating antidepressant-like actions of estrogens are mediated by 5-HT1A and estrogen receptors in the rat forced swimming test. Psychoneuroendocrinology. 2006;31:905–914
  16. Estrada-Camarena E, Fernandez-Guasti A, Lopez-Rubalcava C. Participation of the 5-HT1A receptor in the antidepressant-like effects of estrogens in the forced swimming test. Neuropsychopharmacology. 2006;31:247–255
  17. Filtz TM, Guan W, Artymyshyn RP, Pacheco M, Ford C, Molinoff PB. Mechanisms of up-regulation of D2L dopamine receptors by agonists and antagonists in transfected HEK-293 cells. J. Pharmacol. Exp. Ther. 1994;271:1574–1582
  18. Flugge G, Pfender D, Rudolph S, Jarry H, Fuchs E. 5HT1A-receptor binding in the brain of cyclic and ovariectomized female rats. J. Neuroendocrinol. 1999;11:243–249
  19. Frazer A. Pharmacology of antidepressants. J. Clin. Psychopharm. 1997;17:2S–18S
  20. Freeman ME. The neuroendocrine control of the ovarian cycle of the rat. In:  Knobil E,  Neill J editor. The Physiology of Reproduction. New York: Raven Press; 1988;p. 1893–1928
  21. Halbreich U, Kahn LS. Role of estrogen in the aetiology and treatment of mood disorders. CNS Drugs. 2001;15:797–817
  22. Heffner TG, Hartman JA, Seiden LS. A rapid method for the regional dissection of the rat brain. Pharmacol. Biochem. Behav. 1980;13:453–456
  23. Hope WG, Bruns ME, Thomas ML. Regulation of duodenal insulin-like growth factor I and active calcium transport by ovariectomy in female rats. Proc. Soc. Exp. Biol. Med. 1992;200:528–535
  24. Jacobs PA, Hyland ME. An evaluation of the benefits of taking hormone replacement therapy with other prescription drugs. Maturitas. 2003;46:273–281
  25. Kirby LG, Pan Y-Z, Freeman-Daniels E, Rani S, Nunan JD, Akanwa A, et al. Cellular effects of swim stress in the dorsal raphe nucleus. Psychoneuroendocrinology. 2007;32:712–723
  26. Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, et al. Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am. J. Psychiatry. 2000;157:1445–1452
  27. Le Poul E, Boni C, Hanoun N, Laporte A, Laaris N, Chauveau J, et al. Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine. Neuropharmacology. 2000;39:110–122
  28. Lopez JF, Chalmers DT, Vazquez DM, Watson SJ, Akil H. Serotonin transporter mRNA in rat brain is regulated by classical antidepressants. Biol. Psychiatry. 1994;35:287–290
  29. Lu NZ, Bethea CL. Ovarian steroid regulation of 5-HT1A receptor binding and G protein activation in female monkeys. Neuropsychopharmacology. 2002;27:12–24
  30. Lucki I. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav. Pharmacol. 1997;8:523–532
  31. McQueen JK, Wilson H, Fink G. Estradiol-17β increases serotonin transporter (SERT) mRNA levels and the density of SERT-binding sites in female rat brain. Mol. Brain Res. 1997;45:13–23
  32. Mize AL, Young LJ, Alper RH. Uncoupling of 5-HT1A receptors in the brain by estrogens: regional variations in antagonism by ICI 182,780. Neuropharmacology. 2003;44:584–591
  33. Nagata H, Nozaki M, Nakano H. Short-term combinational therapy of low-dose estrogen with selective serotonin re-uptake inhibitor (fluvoxamine) for oophorectimized women with hot flashes and depressive tendencies. J. Obstet. Gynaecol. Res. 2005;31:107–114
  34. Neumaier JF, Root DC, Hamblin MW. Chronic fluoxetine reduces serotonin transporter mRNA and 5-HT1B mRNA in a sequential manner in the rat dorsal raphe nucleus. Neuropsychopharmacology. 1996;15:515–522
  35. Noble RE. Depression in women. Metab. Clin. Exp. 2005;54:49–52
  36. Osterlund MK, Hurd YL. Acute 17β-estradiol treatment down-regulates serotonin 5HT1A receptor mRNA expression in the limbic system of female rats. Mol. Brain Res. 1998;55:169–172
  37. Page ME, Detke MJ, Dalvi A, Kirby LG, Lucki I. Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology. 1999;147:162–167
  38. Pau KY, Hess DL, Kohama S, Bao J, Pau CY, Spies HG. Oestrogen upregulates noradrenaline release in the mediobasal hypothalamus and tyrosine hydroxylase gene expression in the brainstem of ovariectomized rhesus macaques. J. Neuroendocrinol. 2000;12(9):899–909
  39. Porsolt RD, Le Pichon M, Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature. 1977;266:730–732
  40. Raghupathi RK, Brousseau DA, McGonigle P. Time-course of recovery of 5-HT1A receptors and changes in 5-HT1A receptor mRNA after irreversible inactivation with EEDQ. Mol. Brain Res. 1996;38:233–242
  41. Rasgon NL, Dunkin J, Fairbanks L, Altshuler LL, Troung C, Elman S, et al. Estrogen and response to sertraline in postmenopausal women with major depressive disorder: a pilot study. J. Psychiatric Res. 2006;41:338–343
  42. Schneider LS, Small GW, Clary CM. Estrogen replacement therapy and antidepressant response to sertraline in older depressed women. Am. J. Geriatr. Psychiatry. 2001;9:393–399
  43. Sell SL, Scalzitti JM, Thomas ML, Cunningham KA. Influence of ovarian hormones and estrous cycle on the behavioral response to cocaine in female rats. J. Pharmacol. Exp. Ther. 2000;293:879–886
  44. Sell SL, Thomas ML, Cunningham KA. Influence of estrous cycle and estradiol on behavioral sensitization to cocaine in female rats. Drug Alcohol. Depend. 2002;67:281–290
  45. Shaw AM, Boules M, Zhang Y, Williams K, Robinson J, Carlier PR, et al. Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050. Eur. J. Pharmacol. 2007;555(1):30–36
  46. Stoffel EC, Ulibarri CM, Craft RM. Gonadal steroid hormone modulation of nociception, morphine antinociception and reproductive indices in male and female rats. Pain. 2003;103:285–302
  47. Smith MS, Freeman MF, Neill JD. The control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rat: prolactin, gonadotropin, corpus luteum of pseudopregnancy. Endocrinology. 1975;96:219–226
  48. Sumner BEH, Grant KE, Rosie R, Hegele-Hartung Ch, Fritzemeier KH, Fink G. Effects of tamoxifen on serotonin transporter and 5-hydroxytryptamine2A receptor binding sites and mRNA levels in the brain of ovariectomized rats with or without acute estradiol replacement. Mol. Brain Res. 1999;73:119–128
  49. Zanardi R, Rossini D, Magri L, Malaguti A, Colombo C, Smeraldi E. Response to SSRIs and role of the hormonal therapy in post-menopausal depression. Eur. Neuropsychopharmacol. 2007;17:400–405
  50. Zhou W, Cunningham KA, Thomas ML. Estrogen regulation of gene expression in the brain: a possible mechanism altering the response to psychostimulants in female rats. Mol. Brain Res. 2002;100:75–83
  51. Zhou W, Koldzic-Zivanovic N, Clarke CH, de Beun R, Wassermann K, Bury PS, et al. Selective estrogen receptor modulator effects in the rat brain. Neuroendocrinology. 2002;75:24–33

PII: S0306-4530(08)00128-5

doi: 10.1016/j.psyneuen.2008.05.006

Psychoneuroendocrinology
Volume 33, Issue 8 , Pages 1051-1060 , September 2008

Article Tools

* Image Usage & Resolution